anti-CD93 Molecule (CD93) Anticorps

The protein encoded by CD93 is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. De plus, nous expédions CD93 Protéines (19) et CD93 Kits (13) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
CD93 17064 O89103
CD93 22918 Q9NPY3
CD93 84398 Q9ET61
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-CD93 Anticorps sur anticorps-enligne.fr

Showing 10 out of 76 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Humain Souris Inconjugué IHC (fro), FACS, IP 0.1 mg 6 to 8 Days
$313.50
Détails
Humain Lapin Inconjugué WB Western blot analysis of CD93 expression in KB (A), THP1 (B) whole cell lysates. 200 μL 13 to 14 Days
$487.50
Détails
Humain Souris Inconjugué IHC, ELISA, WB 0.1 mg 3 to 4 Days
$430.10
Détails
Humain Souris Inconjugué ICC, FACS, IHC, ELISA, WB 100 μL 3 to 4 Days
$430.10
Détails
Humain Lapin Inconjugué ELISA, WB Western Blot (WB) analysis of KB cells using CD93 Polyclonal Antibody. 100 μL Disponible
$363.46
Détails
Humain Lapin Inconjugué ELISA, WB Western blot analysis of CD93 using HeLa whole cell lysates ABIN6278318 at 1/100 staining human colon    sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at125¡ãC. An 100 μL 11 to 12 Days
$390.77
Détails
Humain Souris PE FACS 50 Tests 6 to 8 Days
$313.50
Détails
Humain Souris Inconjugué Fig. 1. Black line: Control Antigen (100 ng) Fig. 2. Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using CD93 mouse mAb with DAB staining. 100 μg 11 to 16 Days
$469.05
Détails
Humain Souris Biotin FACS, IHC (fro)   0.1 mg 6 to 8 Days
$577.50
Détails
Souris Rat APC FACS 100 μg 11 to 14 Days
$522.50
Détails

anti-CD93 Anticorps mieux référencés

  1. Human Monoclonal CD93 Primary Antibody pour FACS, Neut - ABIN1177363 : Danet, Luongo, Butler, Lu, Tenner, Simon, Bonnet: C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. dans Proceedings of the National Academy of Sciences of the United States of America 2002 (PubMed)
    Show all 8 Pubmed References

  2. Human Polyclonal CD93 Primary Antibody pour CyTOF, FACS - ABIN4899839 : Mälarstig, Silveira, Wågsäter, Öhrvik, Bäcklund, Samnegård, Khademi, Hellenius, Leander, Olsson, Uhlén, de Faire, Eriksson, Hamsten: Plasma CD93 concentration is a potential novel biomarker for coronary artery disease. dans Journal of internal medicine 2011 (PubMed)
    Show all 4 Pubmed References

  3. Human Monoclonal CD93 Primary Antibody pour ICC, FACS - ABIN1724908 : Ikewaki, Yamao, Kulski, Inoko: Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood. dans Journal of clinical immunology 2010 (PubMed)
    Show all 2 Pubmed References

  4. Mouse (Murine) Monoclonal CD93 Primary Antibody pour CyTOF, FACS - ABIN4899761 : Greenlee-Wacker, Briseño, Galvan, Moriel, Velázquez, Bohlson: Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis. dans Journal of immunology (Baltimore, Md. : 1950) 2011 (PubMed)
    Show all 2 Pubmed References

  5. Human Monoclonal CD93 Primary Antibody pour IHC, ELISA - ABIN1724906 : Kao, Jiang, Pan, Wang, Chen, Wei, Chen, Chang, Shi, Wu: The epidermal growth factor-like domain of CD93 is a potent angiogenic factor. dans PLoS ONE 2012 (PubMed)
    Show all 2 Pubmed References

  6. Human Monoclonal CD93 Primary Antibody pour FACS, IHC (fro) - ABIN111896 : Sumide, Matsuoka, Kawamura, Nakatsuka, Fujioka, Asano, Takihara, Sonoda: A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. dans Nature communications 2018 (PubMed)

Plus d’anticorps contre CD93 partenaires d’interaction

Mouse (Murine) CD93 Molecule (CD93) interaction partners

  1. These findings demonstrate a key role of CD93 in vascular maturation and organization of the extracellular matrix in tumors, identifying it as a potential target for therapy.

  2. CD93 is an important neuro-immune regulator to control central nervous system inflammation.

  3. serum CD93 is a biomarker for allergic asthma

  4. The expression of cd93 was observed in pancreatic islets, and leaky vessels were apparent in cd93-deficient pancreases. We further demonstrated that stress-induced release of sCD93 is impaired by hyperglycemia. Study propose CD93 as an important component in glucometabolic regulation.

  5. soluble EGF-like domain containing CD93 protein is a novel angiogenic factor acting on the endothelium

  6. [review] CD93 regulates inflammation as demonstrated in a murine model of cerebral ischemia reperfusion-induced injury and peritonitis; recent data suggests that a soluble form of CD93 regulates the inflammatory function of monocytes/ macrophages.

  7. these data suggest that cell-associated CD93 regulates leukocyte recruitment and complement activation during murine peritonitis.

  8. we speculate that CD93-neuroprotection is mediated via suppression of the neuroinflammatory response through downregulation of CCL21.

  9. Cd93 may be an autoimmune susceptibility gene residing within the Idd13 locus, which plays a role in regulating absolute numbers of CD4(+) NKT cells.

  10. Data demonstrate that inflammation triggers release of sCD93 in vivo, identify the inflammatory macrophage as a source of sCD93, and provide insight into the mechanism by which CD93 contributes to engulfment of apoptotic cells.

  11. Impaired uptake of apoptotic cells in C1qRp-deficient mice indicates that the C1qRp receptor may contribute to the removal of dying cells in vivo.

  12. CD93-deficient mice were unable to maintain antibody secretion and bone-marrow plasma-cell numbers, demonstrating that CD93 is important for the maintenance of plasma cells in bone marrow niches.

  13. These data suggest that AA4.1 is a cell surface marker that can identify the earliest lymphohematopoietic progenitors in mouse development.

Human CD93 Molecule (CD93) interaction partners

  1. These findings demonstrate a key role of CD93 in vascular maturation and organization of the extracellular matrix in tumors, identifying it as a potential target for therapy.

  2. Report increased CD93 expression in patients with chronic plaque psoriasis and propose the C allele of rs2749817 as a new risk allele for psoriasis.

  3. Results show that CD93 and MMRN2 are co-expressed in the blood vessels of various tumors and their interaction modulates the angiogenic process.

  4. These findings identify novel protein interactions involving CLEC14A, CD93 and CD248 with MMRN2 as targetable components of vessel formation

  5. CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination

  6. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli. The recombinant protein could alter LPS pro-inflammatory activity on THP1 cells.

  7. Vascular CD93 expression is elevated in nasopharyngeal carcinoma and is correlated with T classification, N classification, distant metastasis, clinical stage and poor prognosis (all P < 0.05). In addition, overexpression of CD93 promoted angiogenesis in vitro.

  8. both transmembrane and soluble CD93 are overexpressed in patients with neovascular Age-Related Macular Degeneration.

  9. Elevated serum sCD93 levels reflected exacerbated status of allergic diseases, including CSU [chronic spontaneous urticaria ], AR[allergic rhinitis], and asthma. ICS [inhaled corticosteroid] use significantly diminished serum sCD93 levels in steroid-naive patients with BA[Bronchial asthma]. This result may suggest sCD93 in serum as a therapeutic marker for allergic inflammation.

  10. Data show that CD93 antigen proved to be phosphorylated on tyrosine 628 and 644 following cell adhesion on laminin through dystroglycan.

  11. CD93 expression identifies a predominantly cycling, non-quiescent leukemia-initiating cell population in MLL-rearranged AML, providing opportunities for selective targeting and eradication of LSCs.

  12. The T/T genotype of SNP rs2749817 of CD93 is associated with disseminated cancer.

  13. CD93 is a key regulator of glioma angiogenesis and vascular function, acting via cytoskeletal rearrangements required for cell-cell and cell-matrix adhesion.

  14. These data support a mechanism whereby gC1qR plays an important role in HPV-16 E2-induced human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathway.

  15. The data indicate that gC1qR inhibits viability, migration and proliferation of cervical squamous cells carcinoma via the p38 MAPK signalling pathway.

  16. Antibody-dependent enhancement of parvovirus B19 involves an alternative mechanism mediated by the heat-sensitive complement factor C1q and its receptor, CD93.

  17. Expression of CD93 on the lymphocyte population of peripheral blood cells from infants at 1 month after birth was also significantly decreased, compared with that for neonatal umbilical cord blood.

  18. HPV 16 E2 induces apoptosis by silencing the gC1qR gene or inhibiting p38 MAPK/JNK signalling in cervical squamous cell carcinoma

  19. These data support a mechanism whereby gC1qR induces apoptosis through the mitochondrial and p53-dependent pathways in cervical squamous cell carcinoma.

  20. soluble EGF-like domain containing CD93 protein is a novel angiogenic factor acting on the endothelium

CD93 profil antigène

Profil protéine

The protein encoded by this gene is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. The encoded protein was once thought to be a receptor for C1q, but now is thought to instead be involved in intercellular adhesion and in the clearance of apoptotic cells. The intracellular cytoplasmic tail of this protein has been found to interact with moesin, a protein known to play a role in linking transmembrane proteins to the cytoskeleton and in the remodelling of the cytoskeleton.

Gene names and symbols associated with anti-CD93 Molecule (CD93) Anticorps

  • CD93 antigen (Cd93) anticorps
  • CD93 molecule (CD93) anticorps
  • CD93 molecule (Cd93) anticorps
  • 6030404G09Rik anticorps
  • AA4.1 anticorps
  • AA145088 anticorps
  • AW555904 anticorps
  • C1qR(P) anticorps
  • C1QR1 anticorps
  • C1qRp anticorps
  • CDw93 anticorps
  • dJ737E23.1 anticorps
  • ECSM3 anticorps
  • Ly68 anticorps
  • MXRA4 anticorps

Protein level used designations for anti-CD93 Molecule (CD93) Anticorps

C1q/MBL/SPA receptor , C1qR(p) , cell surface antigen AA4 , complement component 1 q subcomponent receptor 1 , complement component 1, q subcomponent, receptor 1 , complement component C1q receptor , ly-68 , lymphocyte antigen 68 , C1q receptor 1 , C1qR , CD93 antigen , matrix-remodeling-associated protein 4 , matrix-remodelling associated 4

GENE ID SPECIES
17064 Mus musculus
22918 Homo sapiens
84398 Rattus norvegicus
Fournisseurs de qualité sélectionnés pour anti-CD93 (CD93) Anticorps
Avez-vous cherché autre chose?